You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

disability progression

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer, Magnetic Resonance Spectroscopy, Ultra High Field 7T Trial (MRI follow-up)

Not yet recruiting
  • Alzheimer Disease
  • +4 more
  • MRI follow-up
  • (no location specified)
Jun 30, 2023

Multiple Sclerosis, Magnetic Resonance Spectroscopy Trial (magnetic resonance spectroscopy)

Not yet recruiting
  • Multiple Sclerosis
  • Magnetic Resonance Spectroscopy
  • magnetic resonance spectroscopy
  • (no location specified)
Aug 3, 2022

Multiple Sclerosis Trial in Cagliari, Milan (Tailored Physical Activity)

Enrolling by invitation
  • Multiple Sclerosis
  • Tailored Physical Activity
  • Cagliari, Italy
  • +2 more
Sep 25, 2023

Multiple Sclerosis, Secondary Progressive Trial in Calgary (Hydroxychloroquine Pill, Indapamide Pill)

Recruiting
  • Multiple Sclerosis, Secondary Progressive
  • Hydroxychloroquine Pill
  • Indapamide Pill
  • Calgary, Alberta, Canada
    Foothills Medical Centre
May 16, 2022

Spastic Ataxia Trial in Worldwide (Clinical rating scale to measure Ataxia disease severity and progression, Clinical rating

Recruiting
  • Spastic Ataxia
  • Clinical rating scale to measure Ataxia disease severity and progression
  • +3 more
  • Montreal,, Quebec, Canada
  • +8 more
May 17, 2022

Multiple Sclerosis, Primary Progressive Trial in Calgary (Hydroxychloroquine)

Completed
  • Multiple Sclerosis, Primary Progressive
  • Calgary, Alberta, Canada
    MS Clinic Foothills Medical Centre
Jul 28, 2021

Secondary Progressive Multiple Sclerosis (SPMS) Trial in United Kingdom (Simvastatin, Placebo)

Active, not recruiting
  • Secondary Progressive Multiple Sclerosis (SPMS)
  • Belfast, United Kingdom
  • +23 more
Jul 4, 2022

OFSEP Very High Definition Cohort

Not yet recruiting
  • Multiple Sclerosis
  • MRI
  • Lyon, France
  • +4 more
Nov 14, 2022

Multiple Sclerosis, Progressive Multiple Sclerosis Trial in Bergen (Nicotinamid riboside, Placebo)

Not yet recruiting
  • Multiple Sclerosis
  • Progressive Multiple Sclerosis
  • Nicotinamid riboside
  • Placebo
  • Bergen, Norway
    Haukeland University Hospital
Feb 22, 2023

Multiple Sclerosis Trial in Worldwide (MSCopilot® mobile application)

Not yet recruiting
  • Multiple Sclerosis
  • MSCopilot® mobile application
  • Oklahoma City, Oklahoma
  • +6 more
Apr 3, 2023

Multiple Sclerosis Study

Recruiting
  • Multiple Sclerosis
  • +2 more
    • Ljubljana, Osrednjeslovenska, Slovenia
    • +3 more
    Jun 16, 2022

    First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)

    Active, not recruiting
    • Multiple Sclerosis
    • Alexandroupolis, Greece
    • +52 more
    Sep 28, 2022

    Multiple Sclerosis Trial in France (DMT withdrawal, DMT continuation)

    Recruiting
    • Multiple Sclerosis
    • DMT withdrawal
    • DMT continuation
    • Angers, France
    • +22 more
    Mar 25, 2022

    Relapsing Multiple Sclerosis Trial in Worldwide (fenebrutinib, teriflunomide, )

    Recruiting
    • Relapsing Multiple Sclerosis
    • Cullman, Alabama
    • +138 more
    Jan 5, 2023

    Relapsing Multiple Sclerosis Trial in Worldwide (fenebrutinib, teriflunomide, )

    Recruiting
    • Relapsing Multiple Sclerosis
    • Homewood, Alabama
    • +156 more
    Jan 5, 2023

    Multiple Sclerosis Trial (Frexalimab, Placebo, MRI contrast-enhancing agents)

    Not yet recruiting
    • Multiple Sclerosis
    • (no location specified)
    Nov 15, 2023

    Multiple Sclerosis Trial in Aarhus (Systematic exercise training, Educational program)

    Completed
    • Multiple Sclerosis
    • Systematic exercise training
    • Educational program
    • Aarhus, Denmark
      Section for Sport Science, Department of Public Health, Universi
    Nov 2, 2022

    Multiple Sclerosis, Primary Progressive Trial in Worldwide (Ocrelizumab, Placebo)

    Recruiting
    • Multiple Sclerosis, Primary Progressive
    • Scottsdale, Arizona
    • +197 more
    Jan 2, 2023

    Silent Progression Activity Monitoring - SPAM Study

    Not yet recruiting
    • Multiple Sclerosis
    • NO INTERVENTION
    • Nice, France
      CHU de Nice
    Dec 5, 2022

    Multiple Sclerosis, Relapsing-Remitting Trial in United States (Early Aggressive Therapy or Traditional Therapy)

    Recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Early Aggressive Therapy or Traditional Therapy
    • Birmingham, Alabama
    • +51 more
    Jan 23, 2023

    Multiple Sclerosis Trial in France (Ocrelizumab)

    Recruiting
    • Multiple Sclerosis
    • Amiens, France
    • +14 more
    Jul 12, 2022

    MS-ResearchBiomarkerS

    Recruiting
    • Multiple Sclerosis
    • +10 more
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Jan 26, 2022

      Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Demyelinating Autoimmune Diseases, CNS Trial in Amsterdam

      Recruiting
      • Multiple Sclerosis
      • +5 more
      • Amsterdam, Netherlands
        Amsterdam UMC, location VUmc
      Apr 17, 2023

      Brain Abnormalities in Multiple Sclerosis.

      Recruiting
      • Multiple Sclerosis
      • Dimethyl Fumarate 240 MG [Tecfidera]
      • Messina, Italy
        IRCCS Centro Neurolesi "Bonino-Pulejo"
      Mar 31, 2023

      Primary Progressive Multiple Sclerosis Trial in Israel, Moldova, Republic of (GA Depot 40mg once monthly, GA Depot 25mg once

      Recruiting
      • Primary Progressive Multiple Sclerosis
      • GA Depot 40mg once monthly
      • GA Depot 25mg once monthly
      • Haifa, Israel
      • +6 more
      Oct 30, 2022